This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dose Medical Corporation. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Jack Xie: Innovator in Ocular Implants
Introduction
Jack Xie is a prominent inventor based in San Clemente, CA (US). He has made significant contributions to the field of ophthalmology through his innovative work on bioerodible polyester polymer implants. His research focuses on improving treatment options for various eye diseases.
Latest Patents
Jack Xie holds a patent for "Bioerodible polyester polymer axitinib ocular implants and related methods of use." This patent provides compositions that enable the sustained release of a small molecule tyrosine kinase inhibitor, such as axitinib, from a bioerodible polyester polymer implant. The implant is particularly effective for treating ophthalmic conditions, including neovascular age-related macular degeneration and diabetic macular edema. The design allows for intravitreal injection via a small diameter needle, ensuring ease of use and effectiveness. The release of the tyrosine kinase inhibitors from the implants can occur over a period ranging from one week to three years.
Career Highlights
Jack Xie is associated with Dose Medical Corporation, where he continues to advance his research and development efforts. His work has the potential to significantly impact the treatment landscape for patients suffering from serious eye conditions.
Collaborations
Jack collaborates with notable colleagues, including Patrick Michael Hughes and James Shiah, who contribute to his innovative projects and research initiatives.
Conclusion
Jack Xie's contributions to the field of ocular implants exemplify the importance of innovation in medical treatments. His work not only enhances therapeutic options but also showcases the potential of bioerodible materials in healthcare.